What is Humira’s list price per month in 2026?
I can’t determine a “Humira list price per month in 2026” from the information provided here because no 2026 pricing data or list-price schedule was included. List price can also vary by formulation, dosage, and whether you’re looking at the U.S. wholesale acquisition cost (WAC) versus another country’s reference price.
Which “list price” do people usually mean for Humira?
Search results for this topic often hinge on what “list price” means:
- U.S. list price commonly refers to wholesale acquisition cost (WAC), which is published/used for pricing disclosures.
- Some pages instead show a “monthly cost” estimate based on payer discounts or patient out-of-pocket data, which is not the same as list price.
- Outside the U.S., “list price” can be country-specific and may be reported as a tender or regulated benchmark price rather than WAC.
If you want, I can calculate a monthly list price from the right inputs
If you tell me:
1) Country (e.g., U.S.),
2) Strength/formulation (e.g., 40 mg/0.8 mL pen or syringe),
3) Dosing frequency you mean (weekly vs every other week),
4) Whether you want WAC (“list price”) or an insurance/out-of-pocket estimate,
…I can convert the unit price you provide into a per-month figure consistent with your definition.
Common gotcha: Humira may be phased out in some markets
Depending on the market, Humira’s pricing and availability can change around patent/lifecycle events and biosimilar competition. That can affect what you see as “list price” in 2026 versus historical pricing.
If you share the country and the specific product/dose you mean, I’ll help you pin down the per-month list-price number you’re looking for.